Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysis
- Resource Type
- Article
- Source
- In
Blood Advances 8 August 2023 7(15):3984-3992 - Subject
Clinical Trials and Observations Myeloid Neoplasia - Language
- ISSN
- 2473-9529